Scientific Evidences & Presentations

Trifocal performance excellent far, near & intermediate vision
1. Fernandez J. et al. – published in Curr. Eye Res 2018
2. García-Bella J. et al. – published in Eur. J. Ophthalmol. 2018
3. Fernandez J. et al. - WOC 2018 presentation
4. Gyory J. - ESCRS 2017 presentation
Outstanding contrast sensitivity especially in mesopic condition
1. Van Acker E. – ESCRS 2017 presentation
2. Gyory J. - ESCRS 2017 presentation
Complete spectacle independence
1. Dexl A.K. - ESCRS 2015 presentation
2. Van Acker E. – ESCRS 2017 presentation
High patient satisfaction
1. Gyory J. - ESCRS 2017 presentation
2. Dunai A. et al. – ESCRS 2017 presentation
Minimal reports of dysphotopsia
1. García-Bella J. et al. – published in Eur J Ophthalmol. 2018
2. Hernandez- Meijide N. et al. – ASCRS 2018 presentation
Refractive predictability
1. Fernandez J. et al. - WOC 2018 presentation
2. Fernandez J. et al. - ESCRS 2017 presentation

References

“The most balanced trifocal IOL on the market.”

M. Assouline, MD, PhD(France)

“Clinical evidence of prospective randomized study catapulted Liberty into high quality trifocal group of IOLs available on the market.”

E. Van Acker, MD(Belgium)

“After over 100 implantations trifocal performance is evident. Less halos & glare, better contrast sensitivity. All my patients implanted with Liberty are spectacle independent.”

J. Győri, MD(Hungary)
CONTACT US